Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Complementary Medicine and Therapies
Published in: BMC Complementary Medicine and Therapies 1/2016

Open Access 01-12-2016 | Research article

Ex vivo model exhibits protective effects of sesamin against destruction of cartilage induced with a combination of tumor necrosis factor-alpha and oncostatin M

Authors: Manatsanan Khansai, Kanchanit Boonmaleerat, Peraphan Pothacharoen, Thanyaluck Phitak, Prachya Kongtawelert

Published in: BMC Complementary Medicine and Therapies | Issue 1/2016

Login to get access

Abstract

Background

Rheumatoid arthritis (RA) is an autoimmune disease associated with chronic inflammatory arthritis. TNF-α and OSM are pro-inflammatory cytokines that play a key role in RA progression. Thus, reducing the effects of both cytokines is practical in order to relieve the progression of the disease. This current study is interested in sesamin, an active compound in sesame seeds. Sesamin has been shown to be a chondroprotective agent in osteoarthritis models. Here, we have evaluated a porcine cartilage explant as a cartilage degradation model related to RA induced by TNF-α and/or OSM in order to investigate the effects of sesamin on TNF-α and OSM in the cartilage degradation model.

Methods

A porcine cartilage explant was induced with a combination of TNF-α and OSM (test group) or IL-1β and OSM (control group) followed by a co-treatment of sesamin over a long-term period (35 days). After which, the tested explants were analyzed for indications of both the remaining and the degradation aspects using glycosaminoglycan and collagen as an indicator.

Results

The combination of TNF-α and OSM promoted cartilage degradation more than either TNF-α or OSM alone and was comparable with the combination of IL-1β and OSM. Sesamin could be offering protection against cartilage degradation by reducing GAGs and collagen turnover in the generated model.

Conclusions

Sesamin might be a promising agent as an alternative treatment for RA patients. Furthermore, the generated model revealed itself to be an impressive test model for the analysis of phytochemical substances against the cartilage degradation model for RA. The model could be used to test for the prevention of cartilage degradation in other biological agents induced with TNF-α and OSM as well.
Literature
1.
Abeles AM, Pillinger MH. The role of the synovial fibroblast in rheumatoid arthritis: cartilage destruction and the regulation of matrix metalloproteinases. Bull NYU Hosp Jt Dis. 2006;64(1–2):20–4.PubMed
2.
Kirkham BW et al. Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort). Arthritis Rheum. 2006;54(4):1122–31.CrossRefPubMed
3.
Manicourt DH et al. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis. Arthritis Rheum. 2000;43(2):281–8.CrossRefPubMed
4.
Hui W et al. Oncostatin M in combination with tumour necrosis factor {alpha} induces a chondrocyte membrane associated aggrecanase that is distinct from ADAMTS aggrecanase-1 or −2. Ann Rheum Dis. 2005;64(11):1624–32.CrossRefPubMedPubMedCentral
5.
Hui W et al. Oncostatin M in combination with tumor necrosis factor alpha induces cartilage damage and matrix metalloproteinase expression in vitro and in vivo. Arthritis Rheum. 2003;48(12):3404–18.CrossRefPubMed
6.
El Mabrouk M, Sylvester J, Zafarullah M. Signaling pathways implicated in oncostatin M-induced aggrecanase-1 and matrix metalloproteinase-13 expression in human articular chondrocytes. Biochim Biophys Acta. 2007;1773(3):309–20.CrossRefPubMed
7.
McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol. 2007;7(6):429–42.CrossRefPubMed
8.
Nawroth PP et al. Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1. J Exp Med. 1986;163(6):1363–75.CrossRefPubMed
9.
Yoshida S et al. Involvement of thioredoxin in rheumatoid arthritis: its costimulatory roles in the TNF-alpha-induced production of IL-6 and IL-8 from cultured synovial fibroblasts. J Immunol. 1999;163(1):351–8.PubMed
10.
Haworth C et al. Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-alpha. Eur J Immunol. 1991;21(10):2575–9.CrossRefPubMed
11.
12.
Fearon U et al. Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures. Arthritis Rheum. 2006;54(10):3152–62.CrossRefPubMed
13.
Moran EM et al. Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-alpha, Oncostatin M and response to biologic therapies. Arthritis Res Ther. 2009;11(4):R113.CrossRefPubMedPubMedCentral
14.
15.
16.
Zheng ZH et al. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis. Rheumatology (Oxford). 2008;47(1):22–30.CrossRef
17.
Lubke C et al. Growth characterization of neo porcine cartilage pellets and their use in an interactive culture model. Osteoarthritis Cartilage. 2005;13(6):478–87.CrossRefPubMed
18.
Wooley PH. The usefulness and the limitations of animal models in identifying targets for therapy in arthritis. Best Pract Res Clin Rheumatol. 2004;18(1):47–58.CrossRefPubMed
19.
Moo EK, Osman NA, Pingguan-Murphy B. The metabolic dynamics of cartilage explants over a long-term culture period. Clinics (Sao Paulo). 2011;66(8):1431–6.CrossRef
20.
Hou RCW, Ja KCG. Sesamin and sesamolin: natures therapeutic lignans. Curr Enzym Inhib. 2005;1(1):11–20. 10.CrossRef
21.
Utsunomiya T et al. Antioxidant and anti-inflammatory effects of a diet supplemented with sesamin on hepatic ischemia-reperfusion injury in rats. Hepatogastroenterol. 2003;50(53):1609–13.
22.
Jeng KC et al. Sesamin inhibits lipopolysaccharide-induced cytokine production by suppression of p38 mitogen-activated protein kinase and nuclear factor-kappaB. Immunol Lett. 2005;97(1):101–6.CrossRefPubMed
23.
Phitak T et al. Chondroprotective and anti-inflammatory effects of sesamin. Phytochemistry. 2012;80:77–88.CrossRefPubMed
24.
Flannery CR et al. Expression and activity of articular cartilage hyaluronidases. Biochem Biophys Res Commun. 1998;251(3):824–9.CrossRefPubMed
25.
Sekiya I et al. Dexamethasone enhances SOX9 expression in chondrocytes. J Endocrinol. 2001;169(3):573–9.CrossRefPubMed
26.
Farndale RW, Buttle DJ, Barrett AJ. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta. 1986;883(2):173–7.CrossRefPubMed
27.
Dietz Jhar AH. A rapid method for estimating pectic substance in citrus juice. J Food Sci. 1953;18(1–6):169–77.CrossRef
28.
Kolar K. Colorimetric determination of hydroxyproline as measure of collagen content in meat and meat products: NMKL collaborative study. J Assoc Off Anal Chem. 1990;73(1):54–7.PubMed
29.
Badlani N et al. The protective effect of OP-1 on articular cartilage in the development of osteoarthritis. Osteoarthritis Cartilage. 2008;16(5):600–6.CrossRefPubMed
30.
Liu FC et al. Chondroprotective effects and mechanisms of resveratrol in advanced glycation end products-stimulated chondrocytes. Arthritis Res Ther. 2010;12(5):R167.CrossRefPubMedPubMedCentral
31.
Johnson CI, Argyle DJ, Clements DN. In vitro models for the study of osteoarthritis. Vet J. 2016;209:40–9.CrossRefPubMed
32.
Ishiguro N et al. Relationships of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover and inflammation as revealed by analyses of synovial fluids from patients with rheumatoid arthritis. Arthritis Rheum. 2001;44(11):2503–11.CrossRefPubMed
33.
34.
Cawston TE et al. Cytokine synergy, collagenases and cartilage collagen breakdown. Biochem Soc Symp. 2003;70:125–33.CrossRefPubMed
35.
36.
Cawston TE et al. The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint. Arthritis Rheum. 1998;41(10):1760–71.CrossRefPubMed
37.
Scheller J et al. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta. 2011;1813(5):878–88.CrossRefPubMed
38.
Verhoef CM et al. The immune suppressive effect of dexamethasone in rheumatoid arthritis is accompanied by upregulation of interleukin 10 and by differential changes in interferon gamma and interleukin 4 production. Ann Rheum Dis. 1999;58(1):49–54.CrossRefPubMedPubMedCentral
39.
Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol. 1996;14:397–440.CrossRefPubMed
Metadata
Title
Ex vivo model exhibits protective effects of sesamin against destruction of cartilage induced with a combination of tumor necrosis factor-alpha and oncostatin M
Authors
Manatsanan Khansai
Kanchanit Boonmaleerat
Peraphan Pothacharoen
Thanyaluck Phitak
Prachya Kongtawelert
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2016
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-016-1183-0

Other articles of this Issue 1/2016

BMC Complementary Medicine and Therapies 1/2016 Go to the issue

Research article

A dietary strategy for the management of artemether-lumefantrine-induced cardiovascular and renal toxicity

Research article

Rubus occidentalis alleviates hyperalgesia induced by repeated intramuscular injection of acidic saline in rats

Research article

In-vitro alpha amylase inhibitory activity of the leaf extracts of Adenanthera pavonina

Research article

Hominis Placenta facilitates hair re-growth by upregulating cellular proliferation and expression of fibroblast growth factor-7

Research article

Zhengtian Capsule versus flunarizine in patients with migraine: a multi-center, double-blind, double-dummy, randomized controlled, non-inferior clinical trial

Research article

Antibacterial in vitro effects of preparations from Anthroposophical Medicine